Cargando…

B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric Cancers

B-cell lymphoma 6 (BCL6) is a protooncogene in adult and pediatric cancers, first identified in diffuse large B-cell lymphoma (DLBCL) where it acts as a repressor of the tumor suppressor TP53, conferring survival, protection, and maintenance of lymphoma cells. BCL6 expression in normal B cells is fu...

Descripción completa

Detalles Bibliográficos
Autores principales:	McLachlan, Tabitha, Matthews, William C., Jackson, Evangeline R., Staudt, Dilana E., Douglas, Alicia M., Findlay, Izac J., Persson, Mika L., Duchatel, Ryan J., Mannan, Abdul, Germon, Zacary P., Dun, Matthew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716245/ https://www.ncbi.nlm.nih.gov/pubmed/36166198 http://dx.doi.org/10.1158/1541-7786.MCR-22-0567

Ejemplares similares

Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection
por: Staudt, Dilana E., et al.
Publicado: (2022)

Correction to: Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection
por: Staudt, Dilana E., et al.
Publicado: (2023)

Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance
por: Staudt, Dilana, et al.
Publicado: (2018)

Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma
por: Duchatel, Ryan J, et al.
Publicado: (2021)

Reactive Oxygen Species in Acute Lymphoblastic Leukaemia: Reducing Radicals to Refine Responses
por: Mannan, Abdul, et al.
Publicado: (2021)

Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies
por: Findlay, Izac J., et al.
Publicado: (2021)

DIPG-29. PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE (PI3K) INHIBITION DRIVES PROTEIN KINASE C ACTIVATION (PKC) IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
por: Duchatel, Ryan J, et al.
Publicado: (2020)

Hit-and-run lymphomagenesis by the Bcl6 oncogene
por: Green, Michael R, et al.
Publicado: (2014)

The Role of Reactive Oxygen Species in Acute Myeloid Leukaemia
por: Sillar, Jonathan R., et al.
Publicado: (2019)

BCL6, a key oncogene, in the placenta, pre-eclampsia and endometriosis
por: Louwen, Frank, et al.
Publicado: (2022)

Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma
por: Dupont, Thibault, et al.
Publicado: (2015)

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
por: Jackson, Evangeline R., et al.
Publicado: (2023)

Repression of BCL-6 is required for the formation of human memory B cells in vitro
por: Kuo, Tracy C., et al.
Publicado: (2007)

DIPG-32. AKT SIGNALING DRIVES RESISTANCE TO ONC201 IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
por: Jackson, Evangeline R, et al.
Publicado: (2020)

Mastering Sibelius 6
por: Cobas, Gabriel
Publicado: (2011)

Mastering Delphi 6
por: Cantù, Marco
Publicado: (2001)

DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas
por: Lai, Anne Y., et al.
Publicado: (2010)

Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia
por: Humphries, Sam, et al.
Publicado: (2023)

Master Evo 6 : anatomía
Publicado: (2013)

High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan
por: Tsai, Cheng-Chih, et al.
Publicado: (2021)

The oncogene BCL6 is up-regulated in glioblastoma in response to DNA damage, and drives survival after therapy
por: Fabre, Marie-Sophie, et al.
Publicado: (2020)

Making memories with Bcl-6
por: Read, Kaitlin A., et al.
Publicado: (2021)

Mastering MATLAB 6 : a comprehensive tutorial and reference /
por: Hanselman, Duane C.
Publicado: (2001)

ANT and AIL6: masters of the master regulators during flower development
por: Juárez-Corona, Ángela G, et al.
Publicado: (2021)

Mastering VMware vSphere 6
por: Marshall, Nick
Publicado: (2015)

Mastering red hat Linux 6
por: Danesh, Arman
Publicado: (1999)

A Fearless Critic and a Master of Humorous Expression
Publicado: (1919)

Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells
por: Liu, Hui, et al.
Publicado: (2006)

MEF2B mutations lead to deregulated expression of the BCL6 oncogene in Diffuse Large B cell Lymphoma
por: Ying, Carol Y., et al.
Publicado: (2013)

IRF4 as an Oncogenic Master Transcription Factor
por: Wong, Regina Wan Ju, et al.
Publicado: (2022)

SAT-LB056 Is AIP a Tumor Suppressor or an Oncogene? AIP as a Novel Regulator of the Oncogene BCL6 in Diffuse Large B Cell Lymphoma
por: BARRY, SAYKA, et al.
Publicado: (2019)

Small-molecule BCL6 inhibitor protects chronic cardiac transplant rejection and inhibits T follicular helper cell expansion and humoral response
por: Xia, Yuxuan, et al.
Publicado: (2023)

Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
por: Witte, Hanno M., et al.
Publicado: (2023)

Mastering VMware vSphere 6.7
por: Marshall, Nick, et al.
Publicado: (2018)

Significance of Bcl-2 and Bcl-6 immunostaining in B-Non Hodgkin's lymphoma
por: Mahmoud, Hanan Mohamed, et al.
Publicado: (2011)

Bcl-x(L) is an oncogenic driver in colorectal cancer
por: Scherr, Anna-Lena, et al.
Publicado: (2016)

Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma
por: Huge, Nicole, et al.
Publicado: (2019)

Mastering MATLAB 6: a comprehensive tutorial and reference
por: Hanselman, Duane, et al.
Publicado: (2001)

The Ansamycin Antibiotic, Rifamycin SV, Inhibits BCL6 Transcriptional Repression and Forms a Complex with the BCL6-BTB/POZ Domain
por: Evans, Sian E., et al.
Publicado: (2014)

NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in cancer cells
por: Gao, Min, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1slu62bgurdif8q0ic7le0ofnn